181 related articles for article (PubMed ID: 32037147)
1. Implications of IL-13Rα2 in atopic skin inflammation.
Furue M; Ulzii D; Nakahara T; Tsuji G; Furue K; Hashimoto-Hachiya A; Kido-Nakahara M
Allergol Int; 2020 Jul; 69(3):412-416. PubMed ID: 32037147
[TBL] [Abstract][Full Text] [Related]
2. Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Rα2 in Keratinocytes.
Ulzii D; Kido-Nakahara M; Nakahara T; Tsuji G; Furue K; Hashimoto-Hachiya A; Furue M
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284553
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis.
Furue M; Yamamura K; Kido-Nakahara M; Nakahara T; Fukui Y
Allergy; 2018 Jan; 73(1):29-36. PubMed ID: 28670717
[TBL] [Abstract][Full Text] [Related]
4. The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis.
Otsuka A; Nomura T; Rerknimitr P; Seidel JA; Honda T; Kabashima K
Immunol Rev; 2017 Jul; 278(1):246-262. PubMed ID: 28658541
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of interleukin-13 receptor alpha1 on human keratinocytes in the skin of psoriasis and atopic dermatitis.
Wongpiyabovorn J; Suto H; Ushio H; Izuhara K; Mitsuishi K; Ikeda S; Nakao A; Okumura K; Ogawa H
J Dermatol Sci; 2003 Oct; 33(1):31-40. PubMed ID: 14527737
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of the interleukin 4 receptor α promotes T
Brøgger P; Blom LH; Simonsen S; Thyssen JP; Skov L
Scand J Immunol; 2020 Jan; 91(1):e12835. PubMed ID: 31596502
[TBL] [Abstract][Full Text] [Related]
7. Immunological Aspects of Skin Aging in Atopic Dermatitis.
Bocheva GS; Slominski RM; Slominski AT
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072076
[TBL] [Abstract][Full Text] [Related]
8. Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis.
Yang G; Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326002
[TBL] [Abstract][Full Text] [Related]
9. The IL-4Rα Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice.
Yang B; Wilkie H; Das M; Timilshina M; Bainter W; Woods B; Daya M; Boorgula MP; Mathias RA; Lai P; Petty CR; Weller E; Harb H; Chatila TA; Leung DYM; Beck LA; Simpson EL; Hata TR; Barnes KC; Phipatanakul W; Leyva-Castillo JM; Geha RS
J Allergy Clin Immunol; 2023 May; 151(5):1296-1306.e7. PubMed ID: 36690254
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin blocks the IL-13-induced deficiency of Epidermal Barrier Related Proteins via upregulation of miR-143 in HaCaT Keratinocytes.
Jia QN; Zeng YP
Int J Med Sci; 2020; 17(14):2087-2094. PubMed ID: 32922169
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis.
Furue K; Ulzii D; Tanaka Y; Ito T; Tsuji G; Kido-Nakahara M; Nakahara T; Furue M
J Dermatol; 2020 Sep; 47(9):979-988. PubMed ID: 32677165
[TBL] [Abstract][Full Text] [Related]
12. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.
Furue M; Chiba T; Tsuji G; Ulzii D; Kido-Nakahara M; Nakahara T; Kadono T
Allergol Int; 2017 Jul; 66(3):398-403. PubMed ID: 28057434
[TBL] [Abstract][Full Text] [Related]
13. Blockade of OSMRβ signaling ameliorates skin lesions in a mouse model of human atopic dermatitis.
Komori T; Hisaoka T; Kotaki A; Iwamoto M; Miyajima A; Esashi E; Morikawa Y
FASEB J; 2024 Jan; 38(1):e23359. PubMed ID: 38102969
[TBL] [Abstract][Full Text] [Related]
14. The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation.
Mitamura Y; Nunomura S; Nanri Y; Ogawa M; Yoshihara T; Masuoka M; Tsuji G; Nakahara T; Hashimoto-Hachiya A; Conway SJ; Furue M; Izuhara K
Allergy; 2018 Sep; 73(9):1881-1891. PubMed ID: 29528494
[TBL] [Abstract][Full Text] [Related]
15. CYT387, a Novel JAK2 Inhibitor, Suppresses IL-13-Induced Epidermal Barrier Dysfunction Via miR-143 Targeting IL-13Rα1 and STAT3.
Zu Y; Chen XF; Li Q; Zhang ST
Biochem Genet; 2021 Apr; 59(2):531-546. PubMed ID: 33190168
[TBL] [Abstract][Full Text] [Related]
16. Keratinocytes activated by IL-4/IL-13 express IL-2Rγ with consequences on epidermal barrier function.
Progneaux A; Evrard C; De Glas V; Fontaine A; Dotreppe C; De Vuyst E; Nikkels AF; García-González V; Dumoutier L; Lambert de Rouvroit C; Poumay Y
Exp Dermatol; 2023 May; 32(5):660-670. PubMed ID: 36645024
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for itch and disease severity in atopic dermatitis.
Lee CH; Yu HS
Curr Probl Dermatol; 2011; 41():136-148. PubMed ID: 21576954
[TBL] [Abstract][Full Text] [Related]
18. Current Understanding of Pathophysiological Mechanisms of Atopic Dermatitis: Interactions among Skin Barrier Dysfunction, Immune Abnormalities and Pruritus.
Fujii M
Biol Pharm Bull; 2020; 43(1):12-19. PubMed ID: 31902917
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Lipids: Key Mediators of Atopic Dermatitis Pathogenesis.
Bhattacharya N; Sato WJ; Kelly A; Ganguli-Indra G; Indra AK
Trends Mol Med; 2019 Jun; 25(6):551-562. PubMed ID: 31054869
[TBL] [Abstract][Full Text] [Related]
20. Autoreactive T cells and their role in atopic dermatitis.
De Bruyn Carlier T; Badloe FMS; Ring J; Gutermuth J; Kortekaas Krohn I
J Autoimmun; 2021 Jun; 120():102634. PubMed ID: 33892348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
